Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis

Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study

(2014) Farhad Hosseinpanah et al.   CLINICAL ENDOCRINOLOGY

Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome

(2014) Yeon-Ah Sung et al.   FERTILITY AND STERILITY

Prevalence of Metabolic Syndrome Is Higher among Non-Obese PCOS Women with Hyperandrogenism and Menstrual Irregularity in Korea

(2014) Min-Ju Kim et al.   PLoS One

Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype

(2014) Elisabeth Lerchbaum et al.   PLoS One

The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran

(2014) Fahimeh Ramezani Tehrani et al.   Reproductive Biology and Endocrinology

Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics

(2013) Seda Ates et al.   GYNECOLOGICAL ENDOCRINOLOGY

Metabolic Inflexibility Is a Feature of Women With Polycystic Ovary Syndrome and Is Associated With Both Insulin Resistance and Hyperandrogenism

(2013) Daniela Di Sarra et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy of Anti-Leishmania Therapy in Visceral Leishmaniasis among HIV Infected Patients: A Systematic Review with Indirect Comparison

(2013) Gláucia F. Cota et al.   PLoS Neglected Tropical Diseases

Increased mean glucose levels in patients with polycystic ovary syndrome and hyperandrogenemia as determined by continuous glucose monitoring

(2012) JIE-PING ZHU et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism

(2012) Yi Li et al.   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

Polycystic Ovary Syndrome with Hyperandrogenism Is Characterized by an Increased Risk of Hepatic Steatosis Compared to Nonhyperandrogenic PCOS Phenotypes and Healthy Controls, Independent of Obesity and Insulin Resistance

(2012) Helen Jones et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Different Phenotypes of Polycystic Ovary Syndrome: No Advantages for Identifying Women with Aggravated Insulin Resistance or Impaired Lipids

(2011) S. Cupisti et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Is hyperandrogenemia protective for fibrocystic breast disease in PCOS?

(2011) Enis Ozkaya et al.   GYNECOLOGICAL ENDOCRINOLOGY

Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria

(2011) Mehmet Yilmaz et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

The Frequency of Metabolic Syndrome is Higher Among PCOS Brazilian Women With Menstrual Irregularity Plus Hyperandrogenism

(2011) Anderson Sanches Melo et al.   Reproductive Sciences

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan

(2010) H Teede et al.   BMC Medicine

Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism

(2010) Camil Castelo-Branco et al.   GYNECOLOGICAL ENDOCRINOLOGY

Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic

(2010) C. N. Wijeyaratne et al.   HUMAN REPRODUCTION

Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria

(2010) M. Guo et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria

(2008) A.J. Goverde et al.   HUMAN REPRODUCTION